Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-112608
Filing Date
2025-11-14
Accepted
2025-11-14 16:32:10
Documents
64
Period of Report
2025-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nnvc-20250930x10q.htm   iXBRL 10-Q 1178956
2 EX-31.1 nnvc-20250930xex31d1.htm EX-31.1 10945
3 EX-31.2 nnvc-20250930xex31d2.htm EX-31.2 10876
4 EX-32.1 nnvc-20250930xex32d1.htm EX-32.1 6475
5 EX-32.2 nnvc-20250930xex32d2.htm EX-32.2 6646
  Complete submission text file 0001104659-25-112608.txt   5048315

Data Files

Seq Description Document Type Size
6 EX-101.SCH nnvc-20250930.xsd EX-101.SCH 42399
7 EX-101.CAL nnvc-20250930_cal.xml EX-101.CAL 32308
8 EX-101.DEF nnvc-20250930_def.xml EX-101.DEF 189537
9 EX-101.LAB nnvc-20250930_lab.xml EX-101.LAB 318593
10 EX-101.PRE nnvc-20250930_pre.xml EX-101.PRE 251137
67 EXTRACTED XBRL INSTANCE DOCUMENT nnvc-20250930x10q_htm.xml XML 706392
Mailing Address 1 CONTROLS DRIVE SHELTON CT 06484
Business Address 1 CONTROLS DRIVE SHELTON CT 06484 (203) 668-5580
NANOVIRICIDES, INC. (Filer) CIK: 0001379006 (see all company filings)

EIN.: 760674577 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36081 | Film No.: 251487221
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)